A new study shows that when Faro’s Study Designer Tool was applied to clinical trial protocol development, it was easy to visualize, quantify, and therefore recommend, trial improvements.
Faro Health Inc. is pleased to announce the appointment of Vivian DeWoskin as Chief Strategy Officer.
Faro Health Inc. is pleased to announce the appointment of Vivian DeWoskin as Chief Strategy Officer.
A new study shows that when Faro’s Study Designer Tool was applied to clinical trial protocol development, it was easy to visualize, quantify, and therefore recommend, trial improvements.
Faro Health Inc. is pleased to announce the appointment of Patrick Leung as Chief Technology Officer.
Company is using technology to improve protocol design and eliminate operational errors and inefficiencies in clinical trials.
Faro Health Inc. Announces $18.3M in Seed and Series A Funding to Digitize Clinical Development to Transform Clinical Protocol Design.
Faro Health announced that it has strengthened its leadership team with the appointment of Kimberly Pospahala to Vice President of Commercial.
SAN DIEGO, June 8, 2021 /PRNewswire/ — Faro Health Inc., a cloud-computing company that simplifies the design and authoring of complex clinical.
